Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
JL18008 70 μg/kg
DRUG
2 trials
Sponsors
Jecho Biopharmaceuticals Co., Ltd.
Conditions
HIV Infections
Phase 1
A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders
Recruiting
NCT07579741
Jecho Biopharmaceuticals Co., Ltd.
HIV Infections
Start: 2026-05-26
End: 2027-09-28
Target: 30
Updated: 2026-08-06
To Evaluate the Safety of JL18008
Completed
NCT07629310
Jecho Biopharmaceuticals Co., Ltd.
HIV Infections
Start: 2024-06-13
End: 2025-08-05
Updated: 2026-06-11